These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1464103)

  • 1. Synthesis and cardiovascular activity of phenylalkylamine derivatives. I. Potential specific bradycardic agents.
    Ozaki F; Matsukura M; Kabasawa Y; Ishibashi K; Ikemori M; Hamano S; Minami N
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2735-40. PubMed ID: 1464103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
    Kakefuda A; Watanabe T; Taguchi Y; Masuda N; Tanaka A; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):390-8. PubMed ID: 12672990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
    Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3049-52. PubMed ID: 15149642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cardiotonic activity of certain imidazo[2,1-b]-1,3,4-thiadiazole derivatives.
    el-Sherbeny MA; el-Bendary ER; el-Subbagh HI; el-Kashef HA
    Boll Chim Farm; 1997 Mar; 136(3):253-6. PubMed ID: 9164165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and study of new paramagnetic and diamagnetic verapamil derivatives.
    Bognár B; Ahmed S; Kuppusamy ML; Selvendiran K; Khan M; Jeko J; Hankovszky OH; Kálai T; Kuppusamy P; Hideg K
    Bioorg Med Chem; 2010 Apr; 18(8):2954-63. PubMed ID: 20347319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel class of cardiotonics. Synthesis and pharmacological properties of [4-(substituted-amino)phenyl]pyridazinones and related derivatives.
    Okushima H; Narimatsu A; Kobayashi M; Furuya R; Tsuda K; Kitada Y
    J Med Chem; 1987 Jul; 30(7):1157-61. PubMed ID: 3599022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of acidosis on cardiotonic effects of milrinone.
    Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S
    Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
    Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological characterization of some benzazepinone derivatives.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.
    Lillie C; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):331-3. PubMed ID: 3587375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on cardiotonic agents. I. Synthesis of some quinazoline derivatives.
    Nomoto Y; Obase H; Takai H; Hirata T; Teranishi M; Nakamura J; Kubo K
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1591-5. PubMed ID: 2208370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zatebradine, a specific bradycardic agent, on ischemia-induced arrhythmias in anesthetized rabbits.
    Bril A; Forest MC; Cheval B; Landais L; Gout B
    Pharmacology; 1994 May; 48(5):308-19. PubMed ID: 8016191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril.
    Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C
    Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
    Nagy L; Pollesello P; Haikala H; Végh Á; Sorsa T; Levijoki J; Szilágyi S; Édes I; Tóth A; Papp Z; Papp JG
    Eur J Pharmacol; 2016 Mar; 775():120-9. PubMed ID: 26872993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.